Skip to main content
Nivolumab/Ipillimumab combo demonstrates long-term efficacy in NSCLC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Nivolumab/Ipillimumab combo demonstrates long-term efficacy in NSCLC
User login
Username
Password
Reset your password
Concept
Lead
score
Non-Small Cell Lung Cancer
1
1
Lung Cancer
0
0.98
Chemotherapy
0
0.79
Biologic Therapy
0
0.99
Small Cell Lung Cancer
0
0.42
Tumor
0
0.42
Cancer
0
0.33
Skin Cancer
0
0.29
Renal Cell Carcinoma
0
0.28
Quality of Life
0
0.21
Immunotherapy
0
0.97
Lung
0
0.19
Histology
0
0.09
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.9
Pathology & Lab Medicine
0
0.8
Edit Tags